Lilon Huang, a principal engineer of manufacturing operations, delivered a BPI Theater presentation at the BIO International Convention on Wednesday, 5 June 2019, to detail Emergent BioSolution’s efforts to enter the continuous processing arena, specifically the use of multicolumn chromatography. While the move to this technology was designed to reduce costs, Huang explains, it has also created opportunities to partner with industrial leaders in ways that afford crucial feedback for drug design and development.